Skip to main content
    Q

    Q32 Bio Inc (QTTB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $8.63
    +0.34 (+4.10%)

    Market Cap: $248.07M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Q32 Bio Inc (QTTB) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Q32 Bio (QTTB) has a market cap of $248.07M. Its share count is up 177.95% from a year earlier. It holds $289.59M more cash than debt, 116.74% of its market cap.

    Total Valuation

    Market Cap$248.07M
    Latest price (Nov 17, 2026)$8.63

    Key Dates

    The next earnings report is expected on May 3, 2027, covering the quarter ending Mar 31, 2027.

    Next Earnings DateMay 3, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 67.25% in the quarter ended Sep 30, 2026 and grew 67.85% a year over 2 years.

    Shares Outstanding34.02M
    Shares Change (YoY)+177.95%
    Shares Change (QoQ)+67.25%
    Share Count Growth (2Y CAGR)+67.85%

    Valuation Ratios

    Sales and book value multiples are 5.5x and 1.0x.

    P/E Ratio2.6x
    P/S Ratio5.5x
    Forward P/S744.2x
    P/B Ratio1.0x

    Valuation history and multiples

    Price Statistics

    The stock is up 299.54% over 52 weeks and trades 4.96% below its 50-day average.

    Beta (1Y)0.07
    52-Week Change+299.54%
    1-Month Change+10.78%
    3-Month Change-45.52%
    6-Month Change+42.17%
    5-Year Change-91.35%
    Total Return (1Y)+299.54%
    Total Return (3Y CAGR)-5.05%
    Total Return (5Y CAGR)-38.08%
    Return vs SPY (1Y)+266.95%
    Max Drawdown (1Y)-64.83%
    Max Drawdown (3Y)-97.31%
    Sharpe Ratio (1Y)0.96
    Correlation with SPY (1Y)0.01
    50-Day Average$9.08
    200-Day Average$9.53
    52-Week Range$1.91 to $23.57
    RSI (14 Days)45.0
    Average Volume (20 Days)366.09K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 56.34x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio56.34x
    Quick Ratio56.34x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is 11.21% and return on assets is 10.85% over the last 12 months.

    Return on Equity (ROE)11.21%
    Return on Assets (ROA)10.85%
    Return on Capital Employed (ROCE)11.09%
    ROA (5Y Average)-33.01%
    ROIC (5Y Average)-55.81%
    Asset Turnover0.30x

    Scores

    QTTB has an Altman Z-Score of 19.09, in the safe zone above 2.99, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score19.09
    Altman Z ZoneSafe
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $53.74M over the last 12 months.

    Revenue$53.74M
    Gross Profit$53.74M
    Operating Income$18.38M
    Pretax Income$32.25M
    Net Income$32.25M
    EBITDA$32.75M
    EBIT$32.40M
    Reported EPS (TTM)$3.34

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 96.79% of the $297.20M in total assets.

    Cash and Equivalents$289.59M
    Total Debt$0
    Net Cash$289.59M
    Net Cash Per Share$8.51
    Working Capital$285.96M
    Shareholder Equity$287.67M
    Book Value Per Share$8.46
    Total Assets$297.20M
    Total Liabilities$9.53M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$20.02M
    FCF Per Share-$0.67
    Depreciation and Amortization$486.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 34.20%.

    Gross Margin100.00%
    Operating Margin34.20%
    Pretax Margin60.02%
    Net Margin60.02%
    EBITDA Margin60.95%
    EBIT Margin60.29%

    Growth

    Revenue grew 155.87% a year over 3 years.

    Revenue Growth (3Y CAGR)+155.87%
    Revenue Growth (5Y CAGR)+81.85%

    Revenue and profit by year

    Dividends and Yields

    QTTB does not pay a dividend.

    Earnings Yield38.46%
    Buyback Yield-85.56%
    Shareholder Yield-85.56%

    Stock Splits

    The last split was a 1-for-18 reverse split on Mar 26, 2024.

    Last Split DateMar 26, 2024
    Split TypeReverse split
    Split Ratio1:18

    Analyst Forecast

    Consensus estimates put revenue growth at -87.55% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-87.55%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About QTTB

    What is QTTB's market cap?

    Q32 Bio has a market cap of $248.07M.

    What is QTTB's P/E ratio?

    Q32 Bio has a trailing P/E ratio of 2.6x.

    How many shares of QTTB are outstanding?

    Q32 Bio has 34.02M shares outstanding. The count is up 177.95% from a year earlier.

    Does QTTB pay a dividend?

    No. Q32 Bio does not pay a dividend.

    How much debt does QTTB have?

    Q32 Bio has $0 of total debt and $289.59M of cash and equivalents, a net cash position of $289.59M.